Related Experiment Videos
Immunogenetic markers in essential hypertension
Insights
Essential hypertension patients show higher C3-F gene frequency. This genetic marker, along with HLA-B15, may identify individuals at high risk for vascular events like heart disease and stroke.
Area of Science:
- Genetics
- Immunology
- Cardiovascular Medicine
Background:
- Essential hypertension is a major risk factor for cardiovascular disease.
- Genetic predisposition plays a role in hypertension development and its complications.
- Immunological pathways are increasingly recognized in the pathogenesis of vascular diseases.
Purpose of the Study:
- To investigate the association between the C3-F gene and HLA-antigen frequencies in patients with essential hypertension.
- To compare these frequencies with normotensive controls.
- To determine if specific genetic markers can predict the risk of vascular events in hypertensive individuals.
Main Methods:
- Case-control study involving 148 patients with essential hypertension and 62 age/sex-matched normotensive controls.
- Analysis of C3-F gene presence and HLA-antigen frequencies.
- Statistical comparison of genetic marker frequencies between hypertensive patients and controls.
- Risk assessment for coronary heart disease and cerebral events associated with identified genetic markers.
Main Results:
- The C3-F gene was significantly more frequent in hypertensive patients (p < 0.03).
- HLA-B15 was more frequent in hypertensive patients with a positive family history (p < 0.05).
- C3-F gene presence was linked to a 10.2-fold increased risk of coronary heart disease.
- HLA-B15 was linked to a 6.0-fold increased risk of cerebral events.
Conclusions:
- C3-F gene and HLA-B15 antigen determination may aid in identifying hypertensive patients at high risk for vascular events.
- These genetic factors might influence vascular risk independently of blood pressure levels.
- The findings suggest a potential role for genetic and immunological factors in hypertension-related vascular complications.
Abstract:
In a series of 148 patients with essential hypertension, the presence of the atherosclerotic C3-F gene and HLA-antigen frequences were investigated, and the results were compared with those in 62 age and sex matched normotensive controls. The frequency of C3-F was significantly higher in patients (p less than 0.03), as was HLA-B15 in patients with a positive family history of hypertension (p less than 0.05). The presence of the C3-F gene was associated with an increased risk (= 10.2) for coronary heart disease, and B15 was associated with an increased risk (= 6.0) for cerebral events in both familial and non familial cases of hypertension. It is suggested that determination of the C3-F gene and HLA-antigens might be a tool in the identification of hypertensive patients at particular high risk for vascular events, irrespective of BP levels. The study support the suggestions that some genetic factors may act via immunological pathways.